Rephonic
Artwork for Prostate Cancer Update

Prostate Cancer Update

Dr. Neil Love
Prostate Cancer
Pembrolizumab
Urothelial Bladder Cancer
Immunotherapy
Renal Cell Carcinoma
Clinical Trials
Urethral Bladder Cancer
Hormonal Therapy
PARP Inhibitors
Metastatic Urothelial Bladder Cancer
Androgen Receptor Pathway Inhibitors
AKT Inhibitors
Capivasertib
EMBARQ Study
Chemotherapy
Tar-200
Bladder Cancer
Antibody-Drug Conjugates
Circulating Tumor DNA
HER2

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

PublishesDailyEpisodes178Founded20 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Prostate Cancer Update

Latest Episodes

Featuring an interview with Prof Karim Fizazi, including the following topics:

• Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00)

• Mechanism of act... more

YouTube

Featuring an interview with Dr Neeraj Agarwal, including the following topics:

• Impact of PTEN deficiency on PI3K/AKT/mTOR pathway; optimal approaches to testing (0:00)

• Approaches to monitoring for disease progression in patients who are PTEN def... more

YouTube

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:

• Case: A man in his late 70s with diabetes and metastatic bladder cancer achieves radiographic response with enfortumab vedotin (EV) and pembrolizumab but develops un... more

YouTube

Featuring perspectives from Dr Alexandra Drakaki, including the following topics:

• Case: A man in his early 80s with bladder cancer and metastatic progression in the viscera and lymph nodes receives enfortumab vedotin (EV) with pembrolizumab — Part... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
Plenary Session
Plenary SessionVinay Prasad, MD MPH
The Uromigos
The UromigosThe Uromigos

Recent Guests

Karim Fizazi
Prostate cancer research leader at Centre Oscar Lambret
Centre Oscar Lambret
Episode: Prostate Cancer — An Interview with Prof Karim Fizazi
Dr. Neeraj Agarwal
Prostate cancer researcher and clinician
Huntsman Cancer Institute, University of Utah
Episode: Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Fern Anari
Case presenter from Fox Chase Cancer Center
Fox Chase Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 8
Jonathan Anker
Faculty member from Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 8
Jacqueline Brown
Faculty member from Emory University School of Medicine
Emory University School of Medicine
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 8
Naslee Disman
Faculty member from University of Texas MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 8
Catherine Fahey
Faculty member from UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 8
Dr Jonathan Anker
Invited expert discussing a fascinating case with implications for imaging surveillance and treatment
Icahn School of Medicine at Mount Sinai
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 7
Dr Alexandra Drakaki
Co-presenter with Dr Love
UCLA Health Johnson Comprehensive Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 7

Hosts

Dr. Neil Love
Host of the show, medical oncologist guiding the interview
Elisabeth Heath
Moderator of the session
Terence Friedlander
Moderator and physician providing clinical perspective on bladder cancer therapies (UCSF affiliation appears in records)

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#247
New Zealand/Science

Talking Points

Recent interactions between the hosts and their guests.

Prostate Cancer — An Interview with Prof Karim Fizazi
Q: Can you explain what opevesostat does and where androgen receptor mutations fit into the story?
Fizazi explains that some androgen receptor mutations let cancer cells respond to hormones other than androgens. Opevesostat inhibits an early enzyme in steroid production, blocking the production of multiple steroid hormones; he expects its benefit may be concentrated in patients with these mutations.
Prostate Cancer — An Interview with Prof Karim Fizazi
Q: Why have randomized trials not established whether surgery or radiation is better for high-risk localized prostate cancer?
Fizazi says Scandinavian researchers have randomized patients to prostatectomy or radiation with androgen deprivation therapy, but the results are still awaited. He notes that radiation and androgen deprivation therapy remain the main standard of care.
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Q: What is the current clinical stance on using Kapiva Certib in PTEN-deficient metastatic hormone-sensitive disease, including considerations of access and real-world use?
Kapiva Certib is supported by level-one evidence in Kapiva Certib trials for combination therapy, but access and regulatory labeling limit routine use outside trial contexts. In patients with progression after ARPI, off-label use may occur in practice if feasible, with close monitoring for hyperglycemia and other adverse effects.
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Q: How should testing for PTEN loss be approached in this patient population, and what tissue is preferred?
Prefer metastatic tissue when possible, and use IHC to assess PTEN loss with a threshold around 90% for CAPITA testing; if tissue is insufficient, rely on NGS but pursue a fresh metastatic-site biopsy to confirm PTEN status and guide therapy.
Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal
Q: What is the biologic rationale for combining AR pathway inhibition with AKT pathway targeting in PTEN-deficient prostate cancer?
AR pathway inhibitors upregulate AKT signaling, and PTEN loss removes the brake on PI3K-AKT signaling. The combination can therefore drive unchecked growth unless AKT is simultaneously targeted, creating a rationale for adding AKT inhibitors to AR-directed therapy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Prostate Cancer Update

What is Prostate Cancer Update about and what kind of topics does it cover?

This series pulls from leading prostate cancer researchers and clinicians to translate cutting-edge research into practical insight for patient care. Episodes cover treatment strategies across the disease spectrum—from androgen-deprivation therapies and novel hormonal agents to chemotherapy, radiopharmaceuticals, and emerging biomarker-driven approaches like ctDNA. Hosts guide tight, clinician-to-clinician discussions that blend trial data, real-world experience, safety considerations, and patient-centered decision making, with an emphasis on sequencing, toxicity management, and shared decision making in everyday practice. Noteworthy aspects include a strong focus on integrating translational findings into clinical pathways, multidisciplina... more

Where can I find podcast stats for Prostate Cancer Update?

Rephonic provides a wide range of podcast stats for Prostate Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Prostate Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Prostate Cancer Update get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Prostate Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Prostate Cancer Update?

Rephonic provides comprehensive predictive audience data for Prostate Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Prostate Cancer Update have?

To see how many followers or subscribers Prostate Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Prostate Cancer Update?

These podcasts share a similar audience with Prostate Cancer Update:

1. Two Onc Docs
2. Gastrointestinal Cancer Update
3. Lung Cancer Update
4. Plenary Session
5. The Uromigos

How many episodes of Prostate Cancer Update are there?

Prostate Cancer Update launched 20 years ago and published 178 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Prostate Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Prostate Cancer Update?

Rephonic pulls ratings and reviews for Prostate Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Prostate Cancer Update?

Rephonic provides full transcripts for episodes of Prostate Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Prostate Cancer Update?

Recent guests on Prostate Cancer Update include:

1. Karim Fizazi
2. Dr. Neeraj Agarwal
3. Fern Anari
4. Jonathan Anker
5. Jacqueline Brown
6. Naslee Disman
7. Catherine Fahey
8. Dr Jonathan Anker

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days